Of the many young people whom Cathy Eng has treated for cancer, the person who stood out the most was a young woman with a 65-year-old’s disease.
CU Anschutz
Academic Office One
12631 East 17th Avenue
8601
Aurora, CO 80045
Of the many young people whom Cathy Eng has treated for cancer, the person who stood out the most was a young woman with a 65-year-old’s disease.
In this first of four exclusive episodes, MedPage Today brought together three expert leaders in the field -- moderator Michael Wechsler of National Jewish Health in Denver [and professor of medicine at CU School of Medicine], is joined by Flavia Hoyte, also of National Jewish Health [and associate professor of medicine at CU School of Medicine], and Leonard Bacharie of Vanderbilt University Medical Center in Nashville, Tennessee -- for a virtual roundtable discussion on the encouraging new data from these dupilumab studies.
Joshua Barocas, of the University of Colorado School of Medicine in Aurora, urged parents to vaccinate their children if they had not yet done so. “If you are a parent who’s been on the fence, now is the time, given the outbreak potential and the outbreaks that we see, and I would also encourage healthcare workers to welcome people with open, non-judgmental arms,” he said.
For patients with eosinophilic granulomatosis with polyangiitis (EGPA) receiving standard care, benralizumab is noninferior to mepolizumab, according to a study published in the March 7 issue of the New England Journal of Medicine.
12631 East 17th Avenue
8601
Aurora, CO 80045
303-724-1785
© 2024 The Regents of the University of Colorado, a body corporate. All rights reserved.
Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.